AnPac Bio-Medical Science

About:

Anpac Bio-Medical Science is a biotechnology company focusing on early cancer screening and detection.

Website: https://www.anpacbio.com

Twitter/X: anpacbio

Top Investors: Keystone Capital Partners, Zhangjiang Science & Technology Investment Corporation, Yingta Jiankang Guanli

Description:

Anpac Bio-Medical Science is a biotechnology company that focuses on early cancer screening and detection. A variety of cancer screening and detection tests are carried out by AnPac Bio, including tests for biochemistry, immunology, genomics, and CDA (Cancer Differentiation Analysis). AnPaC Bio seeks to unite experts from various fields in order to create, disseminate, and implement accessible early disease detection tools.

Total Funding Amount:

$44.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ambler, Pennsylvania, United States

Founded Date:

2008-01-01

Contact Email:

Info(AT)anpac.cn

Founders:

Chris Yu, Herbert Yu

Number of Employees:

51-100

Last Funding Date:

2023-03-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai